NCT07387783

Brief Summary

This observational cross-sectional study aims to examine the association between sleep quality and cognitive functions in healthy young adults. Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index, and objective sleep parameters will be collected using a wearable device over five consecutive days. Cognitive functions will be evaluated at a single assessment session using standardized neuropsychological tests, including measures of attention, executive functions, and verbal memory. The study seeks to explore relationships between subjective and objective sleep measures and cognitive performance. Findings from this study may contribute to a better understanding of how sleep quality is associated with cognitive functioning in healthy young adults.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
3mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Jan 2026Aug 2026

First Submitted

Initial submission to the registry

January 21, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

January 26, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 4, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

4 months

First QC Date

January 21, 2026

Last Update Submit

April 27, 2026

Conditions

Keywords

sleep qualityCognitive FunctionYoung Adultsverbal memorywearable device

Outcome Measures

Primary Outcomes (1)

  • Composite Objective Sleep Quality Index Derived From Wearable Device

    A composite objective sleep quality index will be derived from wearable device data collected continuously over five consecutive days. The composite score will be calculated by combining standardized values of total sleep time, sleep efficiency, sleep onset latency, and wake after sleep onset into a single summary measure representing overall objective sleep quality.

    During 5 consecutive days around baseline assessment

Secondary Outcomes (3)

  • Sleep Quality (Pittsburgh Sleep Quality Index Scores)

    Baseline (single assessment)

  • Cognitive Performance (Victoria Stroop Test Scores)

    Baseline (single assessment)

  • Verbal Memory Performance (Öktem Verbal Memory Processes Test Scores)

    Baseline (single assessment)

Study Arms (1)

Healthy Young Adults

Healthy young adult participants without diagnosed neurological, psychiatric, or sleep disorders who undergo assessment of sleep quality and cognitive functions during a single observational assessment period.

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of healthy young adults aged between 18 and 35 years. Participants are recruited from a non-clinical population and are required to be fluent in Turkish to ensure valid administration of cognitive assessments. Individuals with self-reported good general health and without active medical, neurological, or psychiatric conditions that may affect sleep or cognitive functioning are eligible. All participants are able and willing to comply with the study procedures, including wearing a wearable sleep monitoring device for five consecutive days and completing a single-session cognitive assessment.

You may qualify if:

  • Between 18 and 35 years.
  • Ability and willingness to provide written informed consent.
  • Sufficient ability to read, understand, and communicate in Turkish, the language in which the assessments are administered.
  • Self-reported good general health, with no active medical or psychiatric conditions that significantly affect daily functioning.
  • Willingness and ability to wear a wearable sleep monitoring device continuously for five consecutive days and to comply with device usage instructions.
  • Ability to attend and complete a single-session cognitive assessment

You may not qualify if:

  • Regular or frequent use of medications known to affect sleep or cognitive function, including sedative-hypnotics, benzodiazepines, antipsychotics, stimulants, opioids, or similar agents.
  • Initiation of, or dose changes in, psychotropic medications within the past four weeks.
  • Being under the influence of alcohol or illicit substances on the day of cognitive testing.
  • Engagement in night shift work or rotating shift schedules within the past one month.
  • Travel across time zones resulting in a time difference of two hours or more within the past two weeks.
  • Uncontrolled high daily intake of caffeine (e.g., \>400 mg/day) and unwillingness to reduce consumption during the study period.
  • Color blindness or other color vision deficiencies, due to their potential impact on Stroop Test performance.
  • Dermatological conditions, allergies, or skin lesions at the wrist that prevent wearing the device, or refusal to wear the device as required.
  • Acute illness within the past two weeks, including febrile infections, severe pain, or other acute medical conditions that may temporarily affect sleep or cognitive performance.
  • Pregnancy or early postpartum period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Üsküdar University

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Fatma Demir, MSc

    Üsküdar University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 21, 2026

First Posted

February 4, 2026

Study Start

January 26, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the study involves sensitive personal data related to sleep patterns and cognitive performance, and participant consent for data sharing was not obtained. Data will be used solely for the purposes defined in the approved study protocol.

Locations